🇺🇸 FDA
Pipeline program

AU-011

AU-011-102

Phase 1 small_molecule active

Quick answer

AU-011 for Non-muscle-invasive Bladder Cancer is a Phase 1 program (small_molecule) at Aura Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Aura Biosciences
Indication
Non-muscle-invasive Bladder Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials